|
|
 |
|
Total Number of Holdings (excluding cash): 50
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$92,148.98 |
2.84% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$91,668.24 |
2.82% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$86,184.50 |
2.66% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$82,779.48 |
2.55% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$82,008.00 |
2.53% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$81,418.24 |
2.51% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$80,788.91 |
2.49% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$79,725.33 |
2.46% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$79,470.72 |
2.45% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$78,478.65 |
2.42% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$77,329.91 |
2.38% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$76,858.86 |
2.37% |
| Waters Corporation |
WAT |
941848103 |
184 |
$76,514.56 |
2.36% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$75,989.60 |
2.34% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$72,999.81 |
2.25% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$72,397.72 |
2.23% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$71,663.20 |
2.21% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$69,855.96 |
2.15% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$69,724.07 |
2.15% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$67,658.28 |
2.08% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$67,284.84 |
2.07% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$67,304.76 |
2.07% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$65,979.89 |
2.03% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$65,565.00 |
2.02% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$64,129.05 |
1.98% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$63,631.88 |
1.96% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$63,532.44 |
1.96% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$63,768.42 |
1.96% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$63,006.36 |
1.94% |
| Steris Plc |
STE |
G8473T100 |
265 |
$62,781.15 |
1.93% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$62,186.45 |
1.92% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$60,797.37 |
1.87% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$60,218.34 |
1.86% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$59,507.70 |
1.83% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$59,156.52 |
1.82% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$58,177.52 |
1.79% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$57,597.68 |
1.77% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$57,105.25 |
1.76% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$56,300.60 |
1.73% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$55,433.60 |
1.71% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$51,703.60 |
1.59% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$51,121.24 |
1.58% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$49,669.55 |
1.53% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$49,240.23 |
1.52% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$47,632.17 |
1.47% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$47,338.07 |
1.46% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$47,253.82 |
1.46% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$45,453.00 |
1.40% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$43,109.18 |
1.33% |
| US Dollar |
$USD |
|
13,565 |
$13,565.44 |
0.42% |
| Yuan Renminbi |
$CNY |
|
1,824 |
$271.01 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|